je.st
news
Merck: Respiratory Medicine Running Out Of Breath
2013-06-26 16:09:16| Biotech - Topix.net
Merck's leading respiratory therapeutic Singulair , a once-a-day oral medicine for the chronic treatment of asthma and for the relief of symptoms of allergic rhinitis which generated more than $44 billion of revenue since its launch in February 1998, lost market exclusivity in the U.S. in August 2012.
Tags: running
medicine
breath
respiratory
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||